In vitro activity of anidulafungin against selected clinically important mold isolates
- PMID: 15105159
- PMCID: PMC400581
- DOI: 10.1128/AAC.48.5.1912-1915.2004
In vitro activity of anidulafungin against selected clinically important mold isolates
Abstract
In this study, we evaluated the in vitro activity of anidulafungin against selected mold isolates. Anidulafungin showed promising activity against Bipolaris spicifera, Exophiala jeanselmei, Fonsecaea pedrosoi, Madurella mycetomatis, Penicillium marneffei, Phialophora verrucosa, Pseudallescheria boydii, Sporothrix schenckii, and Wangiella dermatitidis.
References
-
- Consigny, S., N. Dhedin, A. Datry, S. Choquet, V. Leblond, and O. Chosidow. 2003. Successsful voriconazole treatment of disseminated fusarium infection in an immunocompromised patient. Clin. Infect. Dis. 37:311-313. - PubMed
-
- Denning, D., P. Ribaud, N. Milpied, D. Caillot, R. Herbrecht, E. Thiel, A. Haas, M. Ruhnke, and H. Lode. 2002. Efficacy and safety of voriconazole in the treatment of acute invasive aspergillosis. Clin. Infect. Dis. 34:563-571. - PubMed
-
- Deresinski, S., and D. Stevens. 2003. Caspofungin. Clin. Infect. Dis. 36:1445-1457. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
